Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

11. Februar 2024 21:26 ET | Quelle: Novotech

Novotech Publishes Candidiasis and Rheumatoid Arthritis Clinical Trial Landscape Reports to Support Biotech Research Planning

Novotech CRO has released today two industry-leading reports on the Candidiasis and Rheumatoid Arthritis clinical trial landscapes.
23. Juni 2022 07:58 ET | Quelle: Allied Market Research

Global Antifungal Drugs Market Is Expected to Reach $25.0 Billion by 2030: Allied Market Research

Portland, OR, June 23, 2022 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global Antifungal Drugs Market generated $16.6 billion in 2020, and is projected to...
08. August 2019 16:07 ET | Quelle: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports Second Quarter 2019 Financial Results

SAN DIEGO, Aug. 08, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives, including immunotherapies, today reported financial...
07. August 2019 07:30 ET | Quelle: Cidara Therapeutics, Inc.

Cidara Therapeutics to Present at the 2019 Wedbush PacGrow Healthcare Conference

SAN DIEGO, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that...
29. Juli 2019 07:00 ET | Quelle: Cidara Therapeutics, Inc.

Cidara Therapeutics Reports Positive Topline Results in Phase 2 STRIVE B Trial of Antifungal Rezafungin

Data from second part of successful Phase 2 STRIVE trial further substantiate the efficacy, safety and tolerability of once-weekly rezafungin for first-line treatment of invasive Candida infections ...
09. Mai 2019 16:13 ET | Quelle: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports First Quarter 2019 Financial Results

SAN DIEGO, May 09, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...
03. April 2019 16:04 ET | Quelle: Cidara Therapeutics, Inc.

Cidara Therapeutics to Present at the 18th Annual Needham Healthcare Conference

SAN DIEGO, April 03, 2019 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that...
21. Mai 2018 07:30 ET | Quelle: Cidara Therapeutics, Inc.

Cidara Therapeutics Announces Offering of Common Stock and Warrants

SAN DIEGO, May 21, 2018 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced that it has...
19. Oktober 2017 09:00 ET | Quelle: Cidara Therapeutics, Inc.

Cidara Therapeutics Announces Pricing of $20 Million Private Placement of Common Stock

SAN DIEGO, Oct. 19, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today announced the pricing...
09. August 2017 16:31 ET | Quelle: Cidara Therapeutics, Inc.

Cidara Provides Corporate Update and Reports Second Quarter 2017 Financial Results

SAN DIEGO, Aug. 09, 2017 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq:CDTX), a biotechnology company developing novel anti-infectives including immunotherapies, today reported financial...

Nächste Seite